Global Obesity Treatment Market is anticipated to reach USD 15.6 billion by 2024. Obesity is a disorder wherein extra body fat gets accumulated to such amount that it may have adverse effects on health. The factors that propel the growth of the obesity treatment market include increasing occurrence of obesity and type 2 diabetes, growing consciousness, and improving healthcare infrastructure in developing market such as China, and India, technological advancement.
On
the other hand, there are factors that may hamper the growth of the market
including lack of consciousness towards availability of medication, and high
cost of medicine. Obesity Treatment industry is anticipated to grow at a
significant CAGR in the upcoming period as the scope, product types, and its
applications are increasing across the globe. Obesity Treatment industry may be
explored by drugs type, application, and geography. The market may be explored
by drugs type as Satiety, Appetite Suppressants, Malabsorption, and Combination
Drugs. The “combination drugs” segment led the Obesity Treatment Market in 2015
and is anticipated to maintain its dominance by 2024 due to increasing
occurrence of obesity and the synergistic result of combination therapy in
weight management.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/obesity-treatment-market/request-sample
The
market could be explored based on devices and surgery as Endoscopic Procedures,
Roux-en-Y, Gastric Bypass, Adjusting Gastric Banding, Sleeve Gastrostomy,
Biliopancreatic Diversion with Duodenal Switch, and Others. The “Gastric Bypass”
segment led the Obesity Treatment industry in 2015 and is anticipated to
maintain its dominance by 2024.
North
America accounted for the major share of the Obesity Treatment Market Size in
2015 and will continue to lead in the forecast period. The factors that could
be attributed to the growth includes robust government funding and support,
technical developments in this region, increase in childhood obesity rates,
rising in obese populace, changing lifestyle, surge in membership for health
clubs, and heavy R&D funds deployed to change rational and effective
obesity treatment procedures. North America is followed by Asia-Pacific region.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/obesity-treatment-market
Some of the key players that fuel the growth of the Obesity
Treatment industry comprise Arena Pharmaceuticals, Inc., VIVUS, Inc., Novo
Nordisk A/S, F. Hoffmann-La Roche Ltd., Allergan Plc, Medtronic, Cousin
Biotech, Ethicon (subsidiary of Johnson & Johnson), USGI Medical, Inc., and
Enter Medics, Inc. The leading companies are taking up partnerships, mergers
and acquisitions, and joint ventures in order to boost the inorganic growth of
the industry.
Comments
Post a Comment